(Q46768955)

25 December 2017

title

Improved perfusion with rt-PA and hirulog in a rabbit model of embolic stroke (English)

1 reference

25 December 2017

author name string

M A Yenari

1

1 reference

25 December 2017

A de Crespigny

2

1 reference

25 December 2017

J T Palmer

3

1 reference

25 December 2017

S Roberts

4

1 reference

25 December 2017

S L Schrier

5

1 reference

25 December 2017

G W Albers

6

1 reference

25 December 2017

M E Moseley

7

1 reference

25 December 2017

G K Steinberg

8

1 reference

25 December 2017

publication date

1 April 1997

1 reference

25 December 2017

Journal of Cerebral Blood Flow & Metabolism

published in

1 reference

25 December 2017

volume

17

1 reference

25 December 2017

issue

4

1 reference

25 December 2017

page(s)

401-411

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1097/00004647-199704000-00005

exact match

0 references

cites work

Diffusion nuclear magnetic resonance imaging in experimental stroke. Correlation with cerebral metabolites.

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

Tissue plasminogen activator reduces brain injury in a rabbit model of thromboembolic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

Effect of intra-arterial tissue plasminogen activator and urokinase on autologous arterial emboli in the cerebral circulation of rabbits [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

Hirudin: initial results in acute myocardial infarction, unstable angina and angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

Influence of tissue plasminogen activator and heparin on cerebral ischemia in a rabbit model

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

Evaluation of recombinant tissue plasminogen activator in embolic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

Perfusion and diffusion MR imaging of thromboembolic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

Hemorrhagic transformation following tissue plasminogen activator in experimental cerebral infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

Altered coagulation in cerebral ischemia. Platelet, thrombin, and plasmin activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. The GUSTO investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

Hirudin, heparin, and placebo during deep arterial injury in the pig. The in vivo role of thrombin in platelet-mediated thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

Selective decrease in lysis of old thrombi after rapid administration of tissue-type plasminogen activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

Magnetic resonance imaging assessment of evolving focal cerebral ischemia. Comparison with histopathology in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

Ischemic brain damage: reduction by sodium-calcium ion channel modulator RS-87476.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

Echo-planar perfusion-sensitive MR imaging of acute cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

Modification of acute focal ischemia by treatment with mannitol

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

Pharmacologic reversal of acute changes in diffusion-weighted magnetic resonance imaging in focal cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

Reversible focal ischemic injury demonstrated by diffusion-weighted magnetic resonance imaging in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

Effects of a novel NMDA antagonist on experimental stroke rapidly and quantitatively assessed by diffusion-weighted MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

Diffusion-weighted magnetic resonance imaging of acute focal cerebral ischemia: comparison of signal intensity with changes in brain water and Na+,K(+)-ATPase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

Early detection of regional cerebral ischemia in cats: comparison of diffusion- and T2-weighted MRI and spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

Combined perfusion and diffusion-weighted magnetic resonance imaging in a rat model of reversible middle cerebral artery occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

Tissue plasminogen activator for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

Effect of delayed thrombolysis with rt-PA in a rat embolic stroke model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

Recombinant human tissue-type plasminogen activator therapy in acute thromboembolic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

Tissue plasminogen activator cerebrovascular thrombolysis in rabbits is dependent on the rate and route of administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

Correlation between somatosensory evoked potentials and neuronal ischemic changes following middle cerebral artery occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

Protective effect of N-methyl-D-aspartate antagonists after focal cerebral ischemia in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

Tissue plasminogen activator reduces neurological damage after cerebral embolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

Tissue plasminogen activator. Reduction of neurologic damage after experimental embolic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F00004647-199704000-00005

10.1097/00004647-199704000-00005

21 January 2018

Identifiers

DOI

1 reference

25 December 2017

Dimensions Publication ID

0 references

1 reference

25 December 2017